These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1311181)

  • 21. Modification of alpha-2 presynaptic receptor activity and catecholamine release following chronic MAO inhibition.
    Finberg JP; Ari G; Lavian G; Hovevey-Sion D
    J Neural Transm Suppl; 1990; 32():405-12. PubMed ID: 1965197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guinea-pig vas deferens.
    Driessen B; von Kügelgen I; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):42-8. PubMed ID: 7935853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of forskolin in rat vas deferens--evidence for facilitatory beta-adrenoceptors.
    Hovevei-Sion D; Finberg JP; Bomzon A; Youdim MB
    Eur J Pharmacol; 1983 Nov; 95(3-4):295-9. PubMed ID: 6140180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related changes in norepinephrine release and its modulation by presynaptic alpha-2 adrenoceptors in the rat vas deferens.
    de Avellar MC; Markus RP
    J Pharmacol Exp Ther; 1993 Oct; 267(1):38-44. PubMed ID: 8229766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of alpha 1-adrenoceptors increases [3H]inositol metabolism in rat vas deferens and caudal artery.
    Fox AW; Abel PW; Minneman KP
    Eur J Pharmacol; 1985 Oct; 116(1-2):145-52. PubMed ID: 2865157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separation of adrenergic and non-adrenergic contractions to field stimulation in the rat vas deferens.
    Brown DA; Docherty JR; French AM; MacDonald A; McGrath JC; Scott NC
    Br J Pharmacol; 1983 Jun; 79(2):379-93. PubMed ID: 6317108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens.
    Mallard N; Marshall R; Sithers A; Spriggs B
    Eur J Pharmacol; 1992 Sep; 220(1):1-10. PubMed ID: 1330614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-natal development of functional neurotransmission in rat vas deferens.
    MacDonald A; McGrath JC
    Br J Pharmacol; 1984 May; 82(1):25-34. PubMed ID: 6145467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.
    Bültmann R; Kurz AK; Starke K
    Br J Pharmacol; 1994 Jan; 111(1):151-8. PubMed ID: 7912153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional properties of agmatine in rat vas deferens.
    Jurkiewicz NH; Garcez do Carmo L; Hirata H; da Costa Santos W; Jurkiewicz A
    Eur J Pharmacol; 1996 Jul; 307(3):299-304. PubMed ID: 8836618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of clorgyline on the release of noradrenaline from rat vas deferens.
    Ari G; Finberg JP
    Eur J Pharmacol; 1992 Aug; 219(1):89-96. PubMed ID: 1397052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paired pulse analysis of ATP and noradrenaline release from sympathetic nerves of rat tail artery and mouse vas deferens: effects of K+ channel blockers.
    Msghina M; Gonon F; Stjärne L
    Br J Pharmacol; 1998 Dec; 125(8):1669-76. PubMed ID: 9886758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute and long-term regulation of brain alpha 2-adrenoceptors after manipulation of noradrenergic transmission in the rat.
    Giralt MT; García-Sevilla JA
    Eur J Pharmacol; 1989 May; 164(3):455-66. PubMed ID: 2569977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of release and depletion of endogenous noradrenaline on the transmission of impulses in the mouse vas deferens.
    Marshall I; Nasmyth PA; Shepperson NB
    Br J Pharmacol; 1978 Sep; 64(1):145-51. PubMed ID: 212149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Origin of ATP release in the rat vas deferens: concomitant measurement of [3H]noradrenaline and [14C]ATP.
    Vizi ES; Burnstock G
    Eur J Pharmacol; 1988 Dec; 158(1-2):69-77. PubMed ID: 2851460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of bromocriptine on pre-synaptic and post-synaptic alpha-adrenoceptors in the mouse vas deferens.
    Gibson A; Samini M
    J Pharm Pharmacol; 1979 Dec; 31(12):826-30. PubMed ID: 43367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioenzymatic assay measurement of yohimbine's influence on adrenergic neurotransmission of rat vas deferens: unique consequence of using normetanephrine as an uptake2-blocking agent.
    Saelens DA
    Eur J Pharmacol; 1982 Sep; 83(1-2):11-9. PubMed ID: 6290242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that dopamine is acting at alpha-adrenoceptors of the rat vas deferens.
    Miranda HF; Wolstenholme WW; Moreu GM; Cuevas N; Bustamante D
    J Recept Res; 1990; 10(5-6):317-32. PubMed ID: 1964177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does lithium in vitro and ex vivo alter the release of [3H]noradrenaline from brain tissue and the sensitivity of presynaptic autoreceptors?
    Gross G; Hanft G
    Neuropharmacology; 1990 Sep; 29(9):831-5. PubMed ID: 2293062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.